FDA Adverse Event Injury Summary report: N

PROMETRA II PROGRAMMABLE PUMP

MDR report key: 7068899 · Received November 29, 2017

Report

Report Number
3010079947-2017-00170
Event Type
Injury
Date Received
November 29, 2017
Date of Event
September 22, 2017
Report Date
October 30, 2017
Manufacturer
FLOWONIX MEDICAL, INC.
Product Code
LKK
UDI-DI
00810335020228
PMA / PMN Number
P080012
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

(B)(4). ADDITIONAL INFORMATION WAS RECEIVED FOR COMPLAINT (B)(4).

Additional Manufacturer Narrative · 1

(B)(4). DEVICE EVALUATION: THE DEVICE WAS SUBJECTED TO VISUAL EXTERNAL AND INTERNAL INSPECTION, AS WELL AS FUNCTIONAL, ELECTRICAL, AND FLOW TESTING. THE EVALUATION DETERMINED THAT THE ISSUE WAS LIKELY CAUSED BY A CHEMICAL INTERACTION OCCURRING BETWEEN AN INTERNAL COMPONENT AND THE DRUG. THE DRUG, VALPROATE, WAS USED DURING A CLINICAL INVESTIGATION WITH THE PUMP. BASED ON THE RESULTS OF THE INVESTIGATION, THE REPORTED EVENT WAS CONFIRMED.

Additional Manufacturer Narrative · 1

INTERNAL COMPLAINT NUMBER: (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT SURGICAL INTERVENTION WAS TAKEN TO EXPLANT THE PUMP.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE VOLUME OF UNDELIVERED DRUG REMAINING IN THE DRUG RESERVOIR WAS GREATER THAN THE EXPECTED VOLUME BASED UPON THE PROGRAMMED INFUSION RATE ON FOUR OCCASIONS. PUMP THERAPY IS INTENDED TO TREAT SYMPTOMS ASSOCIATED WITH EPILEPSY WITH 80 MG VALPROATE PER DAY WITH CITRIC ACID AND WITH A DRUG CONCENTRATION OF 150 MG PER ML. THE PATIENT EXPERIENCED INCREASED SEIZURES DURING THE EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
847443 PROMETRA II PROGRAMMABLE PUMP IMPLANTABLE INFUSION PUMP LKK FLOWONIX MEDICAL, INC. 13827 00810335020228

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention